GPA
NVO

Garrison Point Advisors’s Novo Nordisk NVO Stock Holding History

Garrison Point Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.22M Sell
33,268
-3,000
-8% -$142K 0.56% 52
2025
Q4 		$1.85M Hold
36,268
– – 0.82% 30
2025
Q3 		$2.01M Hold
36,268
– – 0.84% 27
2025
Q2 		$2.5M Hold
36,268
– – 1.15% 17
2025
Q1 		$2.52M Hold
36,268
– – 1.22% 17
2024
Q4 		$3.12M Buy
+36,268
New +$3.92M 1.48% 14

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Garrison Point Advisors's NVO Position: Q1 2026 in Review

Garrison Point Advisors reduced its Novo Nordisk (NVO) stake by 8.3% in Q1 2026, selling an estimated $142K and leaving 33,268 shares worth $1.22M. The position accounts for 0.56% of the portfolio, ranked #52.

Garrison Point Advisors first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.12M in Q4 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Garrison Point Advisors held 33,268 shares of Novo Nordisk worth $1.22M as of Q1 2026.
  • Garrison Point Advisors sold 3,000 Novo Nordisk shares in Q1 2026, an estimated $142K.
  • Novo Nordisk made up 0.56% of Garrison Point Advisors's portfolio in Q1 2026, its #52 holding.
  • Garrison Point Advisors first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • Garrison Point Advisors's Novo Nordisk position peaked at $3.12M in Q4 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Garrison Point Advisors's 13F filing for Q1 2026, filed 13 May 2026.